Bio-Path Holdings Inc

Go to Bio-Path Holdings Inc Website

$0.14

0.00 (0.00%)
Live
Previous Close

$0.1449

Day Range

$0.137 - $0.1449

Previous Day Range

$0.141 - $0.1477

Market Cap

$ USD

Day Vol.

16895

Previous Day Vol.

13349

Currency

USD

Primary Exchange

Nasdaq

BIO-PATH HOLDINGS INC...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Bio-Path Holdings, a biotechnology company, announced progress in its clinical trials for cancer and obesity treatments using its DNAbilize® platform. The company highlighted positive results and upcoming milestones for its drug candidates, including prexigebersen, BP1001-A, and BP1002.

Related tickers: BPTH.

Read Full Article

Bio-Path Holdings, a biotechnology company, provides a clinical development and operational update for 2025. The company is advancing multiple programs, including a Phase 2 trial for acute myeloid leukemia, Phase 1/1b trials for solid tumors and relapsed/refractory acute myeloid leukemia, and preclinical development for obesity in Type 2 Diabetes patients.

Related tickers: BPTH.

Read Full Article
Trending Tickers

Please sign in to view